サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1360318

e臨床ソリューション市場：世界の業界分析、規模、シェア、成長、動向、および予測、2023年～2031年

eClinical Solutions Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日: | 発行: Transparency Market Research | ページ情報: 英文 235 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
e臨床ソリューション市場：世界の業界分析、規模、シェア、成長、動向、および予測、2023年～2031年
出版日: 2023年08月24日
発行: Transparency Market Research
ページ情報: 英文 235 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

e臨床ソリューション市場- レポートの範囲

世界のe臨床ソリューション市場に関するTMRのレポートは、過去と現在の成長動向、および2023年から2031年の予測期間中に市場の指標の貴重な洞察を得る機会を研究しています。このレポートは、世界のe臨床ソリューション市場の収益を提供します。 2017年から2031年の期間、2023年を基準年、2031年を予測年とみなします。レポートは、2023年から2031年までの世界のe臨床ソリューション市場の複合年間成長率（CAGR %）も提供します。

このレポートは広範な調査を経て作成されました。1次調査では、調査活動の大部分が行われ、アナリストが主要なオピニオンリーダー、業界リーダー、オピニオンメーカーにインタビューを実施しました。2次調査には、e臨床ソリューション市場を理解するために、主要企業の製品文献、年次報告書、プレスリリース、および関連文書を参照することが含まれます。

市場スナップショット
2023年の市場価値 95億米ドル
2031年の市場価値 299億米ドル
CAGR 13.6%

このレポートは、世界のe臨床ソリューション市場の競合情勢を詳しく掘り下げています。世界のe臨床ソリューション市場で活動する主要企業が特定され、これらのそれぞれがさまざまな属性の観点からプロファイルされています。会社概要、財務状況、最近の動向、 SWOTは、このレポートで紹介されている世界のe臨床ソリューション市場のプレーヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界市場の分析と予測、2017～2031年

第5章 主要な洞察

  • 技術の進歩
  • 規制シナリオ：地域別
  • バリューチェーン分析
  • COVID-19による業界への影響

第6章 世界市場の分析と予測：ソリューションタイプ別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：ソリューションタイプ別、2017-2031
    • 臨床試験管理システム
    • 電子臨床転帰評価
    • ランダム化と試用供給管理
    • 電子データのキャプチャと臨床データの管理
    • 電子治験マスターファイル
    • 患者募集
    • 規制情報管理システム
    • その他
  • 市場魅力分析：ソリューションタイプ別

第7章 世界市場の分析と予測：配信モード別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：配信モード別、2017-2031
    • ライセンスを取得したエンタープライズ/オンプレミス
    • ウェブベース
    • その他
    • クラウドベース/サービスとしてのソフトウェア（SaaS）
  • 市場魅力分析：配信モード別

第8章 世界市場の分析と予測：臨床試験フェーズ別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：臨床試験フェーズ別、2017-2031
    • フェーズI
    • フェーズ II
    • フェーズⅢ
    • フェーズ IV
  • 市場魅力分析：臨床試験フェーズ別

第9章 世界市場の分析と予測：エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：エンドユーザー別、2017-2031
    • 製薬およびバイオテクノロジー企業
    • 医療機器メーカー
    • 受託調査機関
    • その他
  • 市場魅力分析：エンドユーザー別

第10章 世界市場の分析と予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別、2017-2031
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場魅力分析：国・地域別

第11章 北米市場の分析と予測

第12章 欧州市場の分析と予測

第13章 アジア太平洋市場の分析と予測

第14章 ラテンアメリカ市場の分析と予測

第15章 中東およびアフリカ市場の分析と予測

第16章 競合情勢

  • 市場プレーヤー-競合マトリックス（企業の階層および規模別）
  • 市場シェア分析：企業別（2022年）
  • 企業プロファイル
    • ArisGlobal LLC
    • Clario
    • LLC
    • Evidation Health, Inc.
    • Florence Healthcare
    • Advarra, Inc.
    • Dassault Systemes SE（Medidata）
    • Medrio, Inc.
    • Oracle Corporation
    • Parexel Corporation
    • Signant Health
    • Veeva Systems Inc.
    • Viedoc Technologies
    • MedNet Solutions
    • Anju Software, Inc.
    • その他の主要企業
図表

List of Tables

  • Table 01: Global eClinical Solutions Market Value (US$ Bn) Forecast, by Solution Type, 2017-2031
  • Table 02: Global eClinical Solutions Market Value (US$ Bn) Forecast, by Delivery Mode, 2017-2031
  • Table 03: Global eClinical Solutions Market Value (US$ Bn) Forecast, by Clinical Trial Phase, 2017-2031
  • Table 04: Global eClinical Solutions Market Value (US$ Bn) Forecast, by End-user, 2017-2031
  • Table 05: Global eClinical Solutions Market Value (US$ Bn) Forecast, by Region, 2017-2031
  • Table 06: North America eClinical Solutions Market Value (US$ Bn) Forecast, by Country, 2017-2031
  • Table 07: North America eClinical Solutions Market Value (US$ Bn) Forecast, by Solution Type, 2017-2031
  • Table 08: North America eClinical Solutions Market Value (US$ Bn) Forecast, by Delivery Mode, 2017-2031
  • Table 09: North America eClinical Solutions Market Value (US$ Bn) Forecast, by Clinical Trial Phase, 2017-2031
  • Table 10: North America eClinical Solutions Market Value (US$ Bn) Forecast, by End-user, 2017-2031
  • Table 11: Europe eClinical Solutions Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
  • Table 12: Europe eClinical Solutions Market Value (US$ Bn) Forecast, by Solution Type, 2017-2031
  • Table 13: Europe eClinical Solutions Market Value (US$ Bn) Forecast, by Delivery Mode, 2017-2031
  • Table 14: Europe eClinical Solutions Market Value (US$ Bn) Forecast, by Clinical Trial Phase, 2017-2031
  • Table 15: Europe eClinical Solutions Market Value (US$ Bn) Forecast, by End-user, 2017-2031
  • Table 16: Asia Pacific eClinical Solutions Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
  • Table 17: Asia Pacific eClinical Solutions Market Value (US$ Bn) Forecast, by Solution Type, 2017-2031
  • Table 18: Asia Pacific eClinical Solutions Market Value (US$ Bn) Forecast, by Delivery Mode, 2017-2031
  • Table 19: Asia Pacific eClinical Solutions Market Value (US$ Bn) Forecast, by Clinical Trial Phase, 2017-2031
  • Table 20: Asia Pacific eClinical Solutions Market Value (US$ Bn) Forecast, by End-user, 2017-2031
  • Table 21: Latin America eClinical Solutions Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Latin America eClinical Solutions Market Value (US$ Bn) Forecast, by Solution Type, 2017-2031
  • Table 23: Latin America eClinical Solutions Market Value (US$ Bn) Forecast, by Delivery Mode, 2017-2031
  • Table 24: Latin America eClinical Solutions Market Value (US$ Bn) Forecast, by Clinical Trial Phase, 2017-2031
  • Table 25: Latin America eClinical Solutions Market Value (US$ Bn) Forecast, by End-user, 2017-2031
  • Table 26: Middle East & Africa eClinical Solutions Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
  • Table 27: Middle East & Africa eClinical Solutions Market Value (US$ Bn) Forecast, by Solution Type, 2017-2031
  • Table 28: Middle East & Africa eClinical Solutions Market Value (US$ Bn) Forecast, by Delivery Mode, 2017-2031
  • Table 29: Middle East & Africa eClinical Solutions Market Value (US$ Bn) Forecast, by Clinical Trial Phase, 2017-2031
  • Table 30: Middle East & Africa eClinical Solutions Market Value (US$ Bn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global eClinical Solutions Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 02: eClinical Solutions Market Value Share, by Solution Type, 2022
  • Figure 03: eClinical Solutions Market Value Share, by Delivery Mode, 2022
  • Figure 04: eClinical Solutions Market Value Share, by Clinical Trial Phase, 2022
  • Figure 05: eClinical Solutions Market Value Share, by End-user, 2022
  • Figure 06: Global eClinical Solutions Market Value Share Analysis, by Solution Type, 2022 and 2031
  • Figure 07: Global eClinical Solutions Market Attractiveness Analysis, by Solution Type, 2023-2031
  • Figure 08: Global eClinical Solutions Market Value Share Analysis, by Delivery Mode, 2022 and 2031
  • Figure 09: Global eClinical Solutions Market Attractiveness Analysis, by Delivery Mode 2023-2031
  • Figure 10: Global eClinical Solutions Market Value Share Analysis, by Clinical Trial Phase, 2022 and 2031
  • Figure 11: Global eClinical Solutions Market Attractiveness Analysis, Clinical Trial Phase, 2023-2031
  • Figure 12: Global eClinical Solutions Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 13: Global eClinical Solutions Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 14: Global eClinical Solutions Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 15: Global eClinical Solutions Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 16: North America eClinical Solutions Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 17: North America eClinical Solutions Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 18: North America eClinical Solutions Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 19: North America eClinical Solutions Market Value Share Analysis, by Solution Type, 2022 and 2031
  • Figure 20: North America eClinical Solutions Market Attractiveness Analysis, by Solution Type, 2023-2031
  • Figure 21: North America eClinical Solutions Market Value Share Analysis, by Delivery Mode, 2022 and 2031
  • Figure 22: North America eClinical Solutions Market Attractiveness Analysis, by Delivery Mode 2023-2031
  • Figure 23: North America eClinical Solutions Market Value Share Analysis, by Clinical Trial Phase, 2022 and 2031
  • Figure 24: North America eClinical Solutions Market Attractiveness Analysis, Clinical Trial Phase, 2023-2031
  • Figure 25: North America eClinical Solutions Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 26: North America eClinical Solutions Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 27: Europe eClinical Solutions Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 28: Europe eClinical Solutions Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 29: Europe eClinical Solutions Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 30: Europe eClinical Solutions Market Value Share Analysis, by Solution Type, 2022 and 2031
  • Figure 31: Europe eClinical Solutions Market Attractiveness Analysis, by Solution Type, 2023-2031
  • Figure 32: Europe eClinical Solutions Market Value Share Analysis, by Delivery Mode, 2022 and 2031
  • Figure 33: Europe eClinical Solutions Market Attractiveness Analysis, by Delivery Mode 2023-2031
  • Figure 34: Europe eClinical Solutions Market Value Share Analysis, by Clinical Trial Phase, 2022 and 2031
  • Figure 35: Europe eClinical Solutions Market Attractiveness Analysis, Clinical Trial Phase, 2023-2031
  • Figure 36: Europe eClinical Solutions Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 37: Europe eClinical Solutions Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 38: Asia Pacific eClinical Solutions Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 39: Asia Pacific eClinical Solutions Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 40: Asia Pacific eClinical Solutions Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 41: Asia Pacific eClinical Solutions Market Value Share Analysis, by Solution Type, 2022 and 2031
  • Figure 42: Asia Pacific eClinical Solutions Market Attractiveness Analysis, by Solution Type, 2023-2031
  • Figure 43: Asia Pacific eClinical Solutions Market Value Share Analysis, by Delivery Mode, 2022 and 2031
  • Figure 44: Asia Pacific eClinical Solutions Market Attractiveness Analysis, by Delivery Mode 2023-2031
  • Figure 45: Asia Pacific eClinical Solutions Market Value Share Analysis, by Clinical Trial Phase, 2022 and 2031
  • Figure 46: Asia Pacific eClinical Solutions Market Attractiveness Analysis, Clinical Trial Phase, 2023-2031
  • Figure 47: Asia Pacific eClinical Solutions Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 48: Asia Pacific eClinical Solutions Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 49: Latin America eClinical Solutions Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 50: Latin America eClinical Solutions Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 51: Latin America eClinical Solutions Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 52: Latin America eClinical Solutions Market Value Share Analysis, by Solution Type, 2022 and 2031
  • Figure 53: Latin America eClinical Solutions Market Attractiveness Analysis, by Solution Type, 2023-2031
  • Figure 54: Latin America eClinical Solutions Market Value Share Analysis, by Delivery Mode, 2022 and 2031
  • Figure 55: Latin America eClinical Solutions Market Attractiveness Analysis, by Delivery Mode, 2023-2031
  • Figure 56: Latin America eClinical Solutions Market Value Share Analysis, by Clinical Trial Phase, 2022 and 2031
  • Figure 57: Latin America eClinical Solutions Market Attractiveness Analysis, Clinical Trial Phase, 2023-2031
  • Figure 58: Latin America eClinical Solutions Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 59: Latin America eClinical Solutions Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 60: Middle East & Africa eClinical Solutions Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 61: Middle East & Africa eClinical Solutions Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 62: Middle East & Africa eClinical Solutions Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 63: Middle East & Africa eClinical Solutions Market Value Share Analysis, by Solution Type, 2022 and 2031
  • Figure 64: Middle East & Africa eClinical Solutions Market Attractiveness Analysis, by Solution Type, 2023-2031
  • Figure 65: Middle East & Africa eClinical Solutions Market Value Share Analysis, by Delivery Mode, 2022 and 2031
  • Figure 66: Middle East & Africa eClinical Solutions Market Attractiveness Analysis, by Delivery Mode 2023-2031
  • Figure 67: Middle East & Africa eClinical Solutions Market Value Share Analysis, by Clinical Trial Phase, 2022 and 2031
  • Figure 68: Middle East & Africa eClinical Solutions Market Attractiveness Analysis, by Clinical Trial Phase, 2023-2031
  • Figure 69: Middle East & Africa eClinical Solutions Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 70: Middle East & Africa eClinical Solutions Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 71: Global eClinical Solutions Market Share Analysis By Company (2022)
目次
Product Code: TMRGL25508

eClinical Solutions Market - Scope of Report

TMR's report on the global eClinical solutions market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global eClinical solutions market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global eClinical solutions market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the eClinical solutions market.

Market Snapshot
Market Value in 2023US$ 9.5 Bn
Market Value in 2031US$ 29.9 Bn
CAGR13.6%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global eClinical solutions market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global eClinical solutions market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global eClinical solutions market.

The report delves into the competitive landscape of the global eClinical solutions market. Key players operating in the global eClinical solutions market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global eClinical solutions market profiled in this report.

Key Questions Answered in Global eClinical Solutions Market Report:

  • What is the sales/revenue generated by eClinical solutions across all regions during the forecast period?
  • What are the opportunities in the global eClinical solutions market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

eClinical Solutions Market - Research Objectives and Research Approach

The comprehensive report on the global eClinical solutions market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global eClinical solutions market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global eClinical solutions market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global eClinical Solutions Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global eClinical Solutions Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Technological Advancements
  • 5.2. Regulatory Scenario, by Region
  • 5.3. Value Chain Analysis
  • 5.4. COVID-19 impact on the Industry

6. Global eClinical Solutions Market Analysis and Forecast, by Solution Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Solution Type, 2017-2031
    • 6.3.1. Clinical Trial Management Systems
    • 6.3.2. Electronic Clinical Outcome Assessment
    • 6.3.3. Randomization & Trial Supply Management
    • 6.3.4. Electronic Data Capture & Clinical Data Management
    • 6.3.5. Electronic Trial Master Files
    • 6.3.6. Patient Recruitment
    • 6.3.7. Regulatory Information Management Systems
    • 6.3.8. Others
  • 6.4. Market Attractiveness Analysis, by Solution Type

7. Global eClinical Solutions Market Analysis and Forecast, by Delivery Mode

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Delivery Mode, 2017-2031
    • 7.3.1. Licensed Enterprise/On-premise
    • 7.3.2. Web-based
    • 7.3.3. Others
    • 7.3.4. Cloud-based/Software-as-a-service (SaaS)
  • 7.4. Market Attractiveness Analysis, by Delivery Mode

8. Global eClinical Solutions Market Analysis and Forecasts, by Clinical Trial Phase

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Clinical Trial Phase, 2017-2031
    • 8.3.1. Phase I
    • 8.3.2. Phase II
    • 8.3.3. Phase III
    • 8.3.4. Phase IV
  • 8.4. Market Attractiveness Analysis, by Clinical Trial Phase

9. Global eClinical Solutions Market Analysis and Forecast, by End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. Pharmaceutical & Biotechnology Companies
    • 9.3.2. Medical Device Manufacturers
    • 9.3.3. Contract Research Organizations
    • 9.3.4. Others
  • 9.4. Market Attractiveness Analysis, by End-user

10. Global eClinical Solutions Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2017-2031
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness By Country/Region

11. North America eClinical Solutions Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Solution Type, 2017-2031
    • 11.2.1. Clinical Trial Management Systems
    • 11.2.2. Electronic Clinical Outcome Assessment
    • 11.2.3. Randomization & Trial Supply Management
    • 11.2.4. Electronic Data Capture & Clinical Data Management
    • 11.2.5. Electronic Trial Master Files
    • 11.2.6. Patient Recruitment
    • 11.2.7. Regulatory Information Management Systems
    • 11.2.8. Others
  • 11.3. Market Value Forecast, by Delivery Mode, 2017-2031
    • 11.3.1. Licensed Enterprise/On-premise
    • 11.3.2. Web-based
    • 11.3.3. Others
    • 11.3.4. Cloud-based/Software-as-a-service (SaaS)
  • 11.4. Market Value Forecast, by Clinical Trial Phase, 2017-2031
    • 11.4.1. Phase I
    • 11.4.2. Phase II
    • 11.4.3. Phase III
    • 11.4.4. Phase IV
  • 11.5. Market Value Forecast, by End-user, 2017-2031
    • 11.5.1. Pharmaceutical & Biotechnology Companies
    • 11.5.2. Medical Device Manufacturers
    • 11.5.3. Contract Research Organizations
    • 11.5.4. Others
  • 11.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Solution Type
    • 11.7.2. By Delivery Mode
    • 11.7.3. By Clinical Trial Phase
    • 11.7.4. By End-user
    • 11.7.5. By Country/Sub-region

12. Europe eClinical Solutions Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Solution Type, 2017-2031
    • 12.2.1. Clinical Trial Management Systems
    • 12.2.2. Electronic Clinical Outcome Assessment
    • 12.2.3. Randomization & Trial Supply Management
    • 12.2.4. Electronic Data Capture & Clinical Data Management
    • 12.2.5. Electronic Trial Master Files
    • 12.2.6. Patient Recruitment
    • 12.2.7. Regulatory Information Management Systems
    • 12.2.8. Others
  • 12.3. Market Value Forecast, by Delivery Mode, 2017-2031
    • 12.3.1. Licensed Enterprise/On-premise
    • 12.3.2. Web-based
    • 12.3.3. Others
    • 12.3.4. Cloud-based/Software-as-a-service (SaaS)
  • 12.4. Market Value Forecast, by Clinical Trial Phase, 2017-2031
    • 12.4.1. Phase I
    • 12.4.2. Phase II
    • 12.4.3. Phase III
    • 12.4.4. Phase IV
  • 12.5. Market Value Forecast, by End-user, 2017-2031
    • 12.5.1. Pharmaceutical & Biotechnology Companies
    • 12.5.2. Medical Device Manufacturers
    • 12.5.3. Contract Research Organizations
    • 12.5.4. Others
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Solution Type
    • 12.7.2. By Delivery Mode
    • 12.7.3. By Clinical Trial Phase
    • 12.7.4. By End-user
    • 12.7.5. By Country/Sub-region

13. Asia Pacific eClinical Solutions Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Solution Type, 2017-2031
    • 13.2.1. Clinical Trial Management Systems
    • 13.2.2. Electronic Clinical Outcome Assessment
    • 13.2.3. Randomization & Trial Supply Management
    • 13.2.4. Electronic Data Capture & Clinical Data Management
    • 13.2.5. Electronic Trial Master Files
    • 13.2.6. Patient Recruitment
    • 13.2.7. Regulatory Information Management Systems
    • 13.2.8. Others
  • 13.3. Market Value Forecast, by Delivery Mode, 2017-2031
    • 13.3.1. Licensed Enterprise/On-premise
    • 13.3.2. Web-based
    • 13.3.3. Others
    • 13.3.4. Cloud-based/Software-as-a-service (SaaS)
  • 13.4. Market Value Forecast, by Clinical Trial Phase, 2017-2031
    • 13.4.1. Phase I
    • 13.4.2. Phase II
    • 13.4.3. Phase III
    • 13.4.4. Phase IV
  • 13.5. Market Value Forecast, by End-user, 2017-2031
    • 13.5.1. Pharmaceutical & Biotechnology Companies
    • 13.5.2. Medical Device Manufacturers
    • 13.5.3. Contract Research Organizations
    • 13.5.4. Others
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Solution Type
    • 13.7.2. By Delivery Mode
    • 13.7.3. By Clinical Trial Phase
    • 13.7.4. By End-user
    • 13.7.5. By Country/Sub-region

14. Latin America eClinical Solutions Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Solution Type, 2017-2031
    • 14.2.1. Clinical Trial Management Systems
    • 14.2.2. Electronic Clinical Outcome Assessment
    • 14.2.3. Randomization & Trial Supply Management
    • 14.2.4. Electronic Data Capture & Clinical Data Management
    • 14.2.5. Electronic Trial Master Files
    • 14.2.6. Patient Recruitment
    • 14.2.7. Regulatory Information Management Systems
    • 14.2.8. Others
  • 14.3. Market Value Forecast, by Delivery Mode, 2017-2031
    • 14.3.1. Licensed Enterprise/On-premise
    • 14.3.2. Web-based
    • 14.3.3. Others
    • 14.3.4. Cloud-based/Software-as-a-service (SaaS)
  • 14.4. Market Value Forecast, by Clinical Trial Phase, 2017-2031
    • 14.4.1. Phase I
    • 14.4.2. Phase II
    • 14.4.3. Phase III
    • 14.4.4. Phase IV
  • 14.5. Market Value Forecast, by End-user, 2017-2031
    • 14.5.1. Pharmaceutical & Biotechnology Companies
    • 14.5.2. Medical Device Manufacturers
    • 14.5.3. Contract Research Organizations
    • 14.5.4. Others
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Solution Type
    • 14.7.2. By Delivery Mode
    • 14.7.3. By Clinical Trial Phase
    • 14.7.4. By End-user
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa eClinical Solutions Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Solution Type, 2017-2031
    • 15.2.1. Clinical Trial Management Systems
    • 15.2.2. Electronic Clinical Outcome Assessment
    • 15.2.3. Randomization & Trial Supply Management
    • 15.2.4. Electronic Data Capture & Clinical Data Management
    • 15.2.5. Electronic Trial Master Files
    • 15.2.6. Patient Recruitment
    • 15.2.7. Regulatory Information Management Systems
    • 15.2.8. Others
  • 15.3. Market Value Forecast, by Delivery Mode, 2017-2031
    • 15.3.1. Licensed Enterprise/On-premise
    • 15.3.2. Web-based
    • 15.3.3. Others
    • 15.3.4. Cloud-based/Software-as-a-service (SaaS)
  • 15.4. Market Value Forecast, by Clinical Trial Phase, 2017-2031
    • 15.4.1. Phase I
    • 15.4.2. Phase II
    • 15.4.3. Phase III
    • 15.4.4. Phase IV
  • 15.5. Market Value Forecast, by End-user, 2017-2031
    • 15.5.1. Pharmaceutical & Biotechnology Companies
    • 15.5.2. Medical Device Manufacturers
    • 15.5.3. Contract Research Organizations
    • 15.5.4. Others
  • 15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Solution Type
    • 15.7.2. By Delivery Mode
    • 15.7.3. By Clinical Trial Phase
    • 15.7.4. By End-user
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 16.2. Market Share Analysis, by Company (2022)
  • 16.3. Company Profiles
    • 16.3.1. ArisGlobal LLC
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Clario
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. eClinical Solutions LLC
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Evidation Health, Inc.
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Florence Healthcare
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Advarra, Inc.
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Dassault Systemes S.E. (Medidata)
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Medrio, Inc.
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Oracle Corporation
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. Parexel Corporation
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview
    • 16.3.11. Signant Health
      • 16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.11.2. Product Portfolio
      • 16.3.11.3. Financial Overview
      • 16.3.11.4. SWOT Analysis
      • 16.3.11.5. Strategic Overview
    • 16.3.12. Veeva Systems Inc.
      • 16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.12.2. Product Portfolio
      • 16.3.12.3. Financial Overview
      • 16.3.12.4. SWOT Analysis
      • 16.3.12.5. Strategic Overview
    • 16.3.13. Viedoc Technologies
      • 16.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.13.2. Product Portfolio
      • 16.3.13.3. Financial Overview
      • 16.3.13.4. SWOT Analysis
      • 16.3.13.5. Strategic Overview
    • 16.3.14. MedNet Solutions
      • 16.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.14.2. Product Portfolio
      • 16.3.14.3. Financial Overview
      • 16.3.14.4. SWOT Analysis
      • 16.3.14.5. Strategic Overview
    • 16.3.15. Anju Software, Inc.
      • 16.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.15.2. Product Portfolio
      • 16.3.15.3. Financial Overview
      • 16.3.15.4. SWOT Analysis
      • 16.3.15.5. Strategic Overview
    • 16.3.16. Other Prominent Players
      • 16.3.16.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.16.2. Product Portfolio
      • 16.3.16.3. Financial Overview
      • 16.3.16.4. SWOT Analysis
      • 16.3.16.5. Strategic Overview